Marion Schuller
Affiliations: | 2018- | Oxford University UK |
Google:
"Marion Schuller"Mean distance: (not calculated yet)
Parents
Sign in to add mentorStefan Knapp | grad student | Oxford University UK | ||
Benedikt Kessler | grad student | 2014-2017 | Oxford University UK | |
(Investigating strategies to modify PARP14 function through macrodomain inhibition) | ||||
Ivan Ahel | post-doc | 2018- | Oxford University UK |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hloušek-Kasun A, Mikolčević P, Rack JGM, et al. (2022) macrodomain hydrolase SCO6735 cleaves thymidine-linked ADP-ribosylation of DNA. Computational and Structural Biotechnology Journal. 20: 4337-4350 |
Gahbauer S, Correy GJ, Schuller M, et al. (2022) Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2. Biorxiv : the Preprint Server For Biology |
Schuller M, Ahel I. (2022) Beyond protein modification: the rise of non-canonical ADP-ribosylation. The Biochemical Journal. 479: 463-477 |
Schuller M, Butler RE, Ariza A, et al. (2021) Molecular basis for DarT ADP-ribosylation of a DNA base. Nature |
Bajusz D, Wade WS, Satała G, et al. (2021) Exploring protein hotspots by optimized fragment pharmacophores. Nature Communications. 12: 3201 |
Schuller M, Correy GJ, Gahbauer S, et al. (2021) Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Science Advances. 7 |
Schuller M, Correy GJ, Gahbauer S, et al. (2020) Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking. Biorxiv : the Preprint Server For Biology |
Rack JGM, Zorzini V, Zhu Z, et al. (2020) Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential. Open Biology. 10: 200237 |
Moustakim M, Riedel K, Schuller M, et al. (2018) Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2. Bioorganic & Medicinal Chemistry |
Schuller M, Riedel K, Gibbs-Seymour I, et al. (2017) Discovery of a selective allosteric inhibitor targeting macrodomain 2 of poly-adenosine-diphosphate-ribose polymerases 14. Acs Chemical Biology |